Top Markets
Coin of the day
Neuca S.a. Neuca S.a.

Neuca S.a.

NEU
Kedudukan dalam Saham #9484
NEUCA S.A., headquartered in Torun, Poland, specializes in supplying... NEUCA S.A., headquartered in Torun, Poland, specializes in supplying pharmaceutical products to pharmacies and healthcare facilities throughout the country. The firm structures its business around distinct segments: wholesale pharmaceutical distribution, the development and marketing of proprietary drug brands, and a comprehensive healthcare services division. This healthcare arm specifically encompasses outpatient care, clinical trials, and telemedicine. Beyond these core areas, NEUCA S.A. provides an extensive array of additional services, including marketing and advertising support, agency functions, financial solutions, logistics through road cargo transport, accounting and bookkeeping, software development, information technology support, and specialized services for hospitals. The company also offers various insurance products—covering health, property, and other personal lines—and operates its own network of medical supply stores. Established in 1990 as Torfarm SA, the company rebranded to NEUCA S.A. in April 2010.
Harga Saham
$222.12
Disegerakkan terakhir: 2026-08-28
Modal Pasaran
$1.00B
Perubahan (1 hari)
-0.75%
Perubahan (1 tahun)
24.88%
Negara
PL
Perdagangan Neuca S.a. (NEU)

Kategori

Pendapatan untuk Neuca S.a. (NEU)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Neuca S.a., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Neuca S.a. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$6.46B -
US
- -
US
$2.17B -
US
- -
US
$708.86M -
AU